Most lately, it has been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to some big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts like a scavenger and does not activate a